COVID-19 related multisystem inflammatory syndrome in children: a case series from a tertiary care hospital
DOI:
https://doi.org/10.18203/2320-6012.ijrms20232800Keywords:
MIS-C, COVID-19, KDAbstract
Multisystem inflammatory syndrome in children (MIS-C) is a rare but serious medical condition associated with COVID-19. Approximately 40-50% of children with MIS-C meet criteria for complete or incomplete Kawasaki disease (KD). In this study, we aim to review and summarize the clinical presentation, laboratory parameters, outcome and management of MIS-C cases presenting to a tertiary care pediatric hospital of RRMCH. Here we report the case series of 7 children diagnosed with MISC. To study the clinical presentation, laboratory parameters, outcome and management of MIS-C cases presenting to a tertiary care pediatric hospital, RRMCH. Retrospective observational study done for a period of 10 months from June 2021 to March 2022. Detailed history taking, clinical examination, laboratory workup, management and outcome recorded were studied. During this period, a total of 22 children were positive for COVID-19 by RT-PCR, and 7 of these patients fulfilled the WHO criteria for MIS-C and were managed in our hospital. The study showed male preponderance with most common feature of presentation being fever constituting to 85.7%, 100% showing hyper inflammatory status and 4 out of 7 patients having cardiac involvement and zero mortality rate. Due to the increasing trend of post covid complications, strong clinical suspicion is required to diagnose MIS-C. As this condition has severe effects on major systems, awareness among pediatricians is required for timely evaluation and treatment to prevent morbidity and mortality associated with MIS-C.
Metrics
References
Latimer G, Corriveau C, DeBiasi RL, Jantausch B, Delaney M, Jacquot C et al. Cardiac dysfunction and thrombocytopenia-associated multiple organ failure inflammation phenotype in a severe paediatric case of COVID-19. Lancet Child Adolesc Heal. 2020;4:2.
Kaushik S, Aydin SI, Derespina KR, Bansal PB, Kowalsky S, Trachtman R et al. Multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2 infection: a multi-institutional study from New York City J Pediatr. 2020;224:24-9.
Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324:259-69.
Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. (2020)395:1771-8.
Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383:347-58.
Nisha MS, Oliver MT, Mullins EWS. SARS-CoV-2 (COVID-19): What do we know about children? A systematic review. Clin Infect Dis. 2020;954162:1-4.
Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Bradley Segal J et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020;10:537-40.
Bourrely C. COVID-19 and Kawasaki Like Disease: the Known-Known, the Unknown- Known and the Unknown-Unknown. 2020. Available at: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-inflammatory~syndrome-20200501.pdf. Accessed on 23 June, 2023.
Royal College of Paediatrics and Child Health. Guidance: Paediatric Multisystem Inflammatory Syndrome Temporally Associated With COVID-19. London: The Royal College of Paediatrics and Child Health. 2020.
Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607-8.
Dallan C, Romano F, Siebert J, Politi S, Lacroix L, Sahyoun C. Septic shock presentation in adolescents with COVID-19. Lancet Child Adolesc Heal. 2020;4:21-3.
Belhadjer Z, Méot M, Bajolle F, Khraiche D, Legendre A, Abakka S et al. Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142:429-36.
World Health Organization. Multisystem Inflammatory Syndrome in Children and Adolescents Temporally Related to COVID-19. Available at: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatorysyndrome-in-children-and-adolescents-with-covid-19. Accessed on 23 June, 2023.
Licciardi F, Pruccoli G, Denina M, Parodi E, Taglietto M, Rosati S et al. SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics. 2020;146:1-5.
Coronavirus disease 2019 (COVID-19): Clinical features. Available at: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-clinical-features?topicRef=126981&source=see_link. Accessed on 15 May, 2023.
Coronavirus disease 2019 (COVID-19): Multisystem inflammatory syndrome in children (MIS-C) clinical features, evaluation, and diagnosis. Available at: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-multisystem-inflammatory-syndrome-in-children-mis-c-clinical-features-evaluation-and-diagnosis?topicRef=129614&source=see_link. Accessed on 15 May, 2023.
Multisystem Inflammatory Syndrome (MIS-C). Available at: https://www.cdc.gov/coronavirus/2019-ncov/daily-life-coping/children/mis-c.html. Accessed on 15 May, 2023.
Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334-46.
Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J et al. Multisystem inflammatory syndrome in children in New York state. N Engl J Med. 2020;383(4):347-58.
Downloads
Published
How to Cite
Issue
Section
